Sanofos IV

Sanofos IV

fosfomycin

Manufacturer:

Able Medical

Distributor:

Universal Medical Industry

Marketer:

Able Medical
Concise Prescribing Info
Contents
Fosfomycin Na
Indications/Uses
Osteomyelitis; complicated UTI; nosocomial lower resp tract infections; bacterial meningitis; bacteraemia in association w/, or suspected to be associated w/ infections in adult & childn including neonates.
Dosage/Direction for Use
IV Administer at least 15 min for 2 g & at least 30 min for 4 g. Adult & adolescent >12 yr weighing >40 kg w/ CrCl >80 mL/min Max individual dose: Not to exceed 8 g. Osteomyelitis, nosocomial lower resp tract infection 12-24 g in 2-3 divided doses. Complicated UTI 12-16 g in 2-3 divided doses. Bacterial meningitis 16-24 g in 3-4 divided doses. High-dose regimen in 3 divided doses is used in severe infections expected or known to be caused by less susceptible bacteria. Childn 1-12 yr & infant weighing 10-40 kg 200-400 mg/kg in 3-4 divided doses; infant 1-12 mth weighing up to 10 kg 200-300 mg/kg in 3 divided doses; neonate 40-44 wk 200 mg/kg in 3 divided doses; premature neonate <40 wk 100 mg/kg in 2 divided doses. Renal impairment Increased loading dose up to 100%; not to exceed 8 g. CrCl 40 mL/min 70% of appropriate dose in normal renal function in 2-3 divided doses; 30 mL/min 60% of appropriate dose in normal renal function in 2-3 divided doses; 20 mL/min 40% of appropriate dose in normal renal function in 2-3 divided doses; 10 mL/min 20% of appropriate dose in normal renal function in 1-2 divided doses. Patient undergoing chronic intermittent dialysis every 48 hr 2 g at the end of each dialysis session.
Contraindications
Special Precautions
Discontinue if acute, potentially life-threatening hypersensitivity reactions; Clostridium difficile occurs. Patients w/ cardiac insufficiency, HTN, hyperaldosteronism, hypernatraemia or pulmonary oedema; diarrhoea during or subsequent treatment. Antibacterial agent-associated colitis & pseudomembranous colitis. Consider low Na diet. Monitor serum electrolyte levels & water balance during therapy; blood K levels during prolonged treatment w/ high doses, particularly in digitalized heart failure patients. Not to be given concomitantly w/ drugs that inhibit peristalsis. Coadministration w/ another antibacterial agent. May affect ability to drive & use machines. Severe renal insufficiency (CrCl ≤40 mL/min). Not to be used during pregnancy. Not to be administered during lactation. Childn w/ renal impairment. Elderly w/ impaired renal function.
Adverse Reactions
Hypernatraemia &/or hypokalaemia; retching, stomach ache; erythematous eruption; inj site phlebitis.
MIMS Class
Other Antibiotics
ATC Classification
J01XX01 - fosfomycin ; Belongs to the class of other antibacterials. Used in the systemic treatment of infections.
Presentation/Packing
Form
Sanofos IV powd for infusion 2 g
Packing/Price
1's
Form
Sanofos IV powd for infusion 4 g
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in